Discovery & Development Advanced Medicine, Drug Discovery, Formulation, Trends & Forecasts

Video Interview: Vered Caplan

We recently had the pleasure of video interviewing Vered Caplan, CEO of Orgenesis, at the latest ISCT convention in Paris (2023).

Jamie Irvine | 07/27/2023 | Video

Covering everything from manufacturing, regulatory relations, and future prospects for growth – join us as we gain detailed insights on the latest industry trends from Vered Caplan!

Vered Caplan is an active entrepreneur in the life science space. From founding and leading over 15 companies, to spearheading the development of Orgenesis as CEO, her experience extends across OTC products, pharmaceuticals, biologics, cell therapy and medical devices.

In the past Vered held the position of CEO at Kamedis, CEO of Gammacan International, and President for Catalent MSTC.Vered’s career began in Life Sciences after receiving a graduate degree from Tel-Aviv University and an undergraduate degree from Technion-Israel Institute of Technology.

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Discovery & Development Advanced Medicine, Drug Discovery, Formulation, Trends & Forecasts

Jamie Irvine

Associate Editor, The Medicine Maker